Intagenta 40mg Injection

Composition Gentamicin (40mg)
Rx Prescription Required
Pack vial of 30 ml Injection
Storage Store below 30°C
Chemical Class Aminoglycosides
Action Class Bacterial Protein Synthesis Inhibitors- Aminoglycosides
Habbit Forming
Manufacturer Intas Pharmaceuticals Ltd
Manufacturer address Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad – 380009. Gujarat. India.

Intagenta 40mg Injection is an antibiotic used to prevent or treat a wide variety of bacterial infections. This may include infections of the urinary tract, bones and joints, lungs (e.g., pneumonia), brain (e.g., meningitis), sepsis, and some others. However, it is not effective for gonorrhea.

Intagenta 40mg Injection is also widely used in hospitalized patients to prevent infections. It works by stopping the growth of bacteria. It is given as a drip (intravenous infusion) or as an injection directly into a vein or a muscle under the supervision of a healthcare professional. Your doctor may shift you to another antibiotic after culture reports become available. It should be used regularly at evenly spaced time intervals as prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.

This medicine may lead to kidney damage and hearing loss as side effects in some patients. Therefore, it is important to follow all the instructions given by your doctor while using this medicine. It may also cause balance disorder (loss of balance) and injection site pain in some people. 

Your doctor may monitor you with regular kidney function tests or hearing tests during treatment. Some patients may also be advised to get blood levels of this medicine measured. Before using this medicine, inform your doctor if you are pregnant, planning to become, or breastfeeding.

Bacterial infections

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Intagenta 40mg Injection is an antibiotic. It stops bacterial growth by preventing synthesis of essential proteins required by bacteria to carry out vital functions.

Q: What if you forget to take Intagenta Injection?
A: If you miss a dose of Intagenta 40mg Injection, please consult your doctor.

Q. Is Intagenta 40mg Injection safe?

Intagenta 40mg Injection is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor’s instructions carefully and let your doctor know if any of the side effects bother you.

Q. How is Intagenta 40mg Injection administered?

Intagenta 40mg Injection should be administered under the supervision of a trained healthcare professional or a doctor only and should not be self-administered. The dose will depend on the condition you are being treated for and will be decided by your doctor. Follow your doctor’s instructions carefully to get maximum benefit from Intagenta 40mg Injection.

Q. Can I take a higher than the recommended dose of this medicine?

No, Intagenta 40mg Injection should be taken in the recommended dose only. Overdose of Intagenta 40mg Injection can increase the risks of side effects. If you experience an increase in the severity of your symptoms during the treatment, please consult your doctor for re-evaluation.

Q. What are the instructions for the storage and disposal of Intagenta 40mg Injection?

Keep this medicine in the container or the pack it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

Q. Is Intagenta 40mg Injection effective?

Intagenta 40mg Injection is effective if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop using Intagenta 40mg Injection too early, the symptoms may return or worsen.

Q. What if I don’t get better after using Intagenta 40mg Injection?

Inform your doctor if you don’t feel better after finishing the full course of treatment. Also, consult your doctor if your symptoms are getting worse while using this medicine. The doctor may modify the dose or suggest an alternative medicine.

Q. Can I stop taking Intagenta 40mg Injection when I feel better?

No, do not stop taking Intagenta 40mg Injection without consulting the doctor even if you are feeling better. You may experience improvement in your symptoms before the infection is completely cleared. Therefore, for better results, it is advised to continue your treatment for the prescribed duration.

Hearing loss

Kidney damage

Balance disorder (loss of balance)

Injection site pain

Alcohol:SAFE

Consuming alcohol with Intagenta 40mg Injection does not cause any harmful side effects.

Pregnancy:CONSULT YOUR DOCTOR

Intagenta 40mg Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.

Breast feeding:SAFE IF PRESCRIBED

Intagenta 40mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.

Driving:UNSAFE

Intagenta 40mg Injection may cause side effects which could affect your ability to drive.

Kidney:CAUTION

Intagenta 40mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Intagenta 40mg Injection may be needed. Please consult your doctor.

Liver:CONSULT YOUR DOCTOR

There is limited information available on the use of Intagenta 40mg Injection in patients with liver disease. Please consult your doctor.

MacDougall C, Chambers HF. Aminoglycosides. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1515-16.
Chambers HF, Deck DH. Aminoglycosides & Spectinomycin. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 811-12.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 620-22.
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 31 Mar. 2019] (online) Available from: View
Central Drugs Standard Control Organisation (CDSCO). [Accessed 31 Mar. 2019] (online) Available from: View